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Abstract
In order to develop a medical alternative to surgical ovarian diathermy (OD) in polycystic ovary syndrome (PCOS) more
mechanistic information is required about OD. We therefore studied the cellular, molecular and vascular effects of
diathermy on the ovary using an established ovine model of PCOS. Pregnant sheep were treated twice weekly with
testosterone propionate (100 mg) from day 30–100 gestation. Their female offspring (n = 12) were studied during their
second breeding season when the PCOS-like phenotype, with anovulation, is fully manifest. In one group (n = 4) one ovary
underwent diathermy and it was collected and compared to the contralateral ovary after 24 hours. In another group a
treatment PCOS cohort underwent diathermy (n = 4) and the ovaries were collected and compared to the control PCOS
cohort (n = 4) after 5 weeks. Ovarian vascular indices were measured using contrast-enhanced ultrasound and colour
Doppler before, immediately after, 24 hours and five weeks after diathermy. Antral follicles were assessed by
immunohistochemistry and ovarian stromal gene expression by quantitative RT-PCR 24 hours and 5 weeks after diathermy.
Diathermy increased follicular atresia (P,0.05) and reduced antral follicle numbers after 5 weeks (P,0.05). There was an
increase in stromal CCL2 expression 24 hours after diathermy (P,0.01) but no alteration in inflammatory indices at 5 weeks.
Immediately after diathermy there was increased microbubble transit time in the ovarian microvasculature (P= 0.05) but this
was not seen at 24 hours. However 24 hours after diathermy there was a reduction in the stromal Doppler blood flow signal
(P,0.05) and an increased ovarian resistance index (P,0.05) both of which persisted at 5 weeks (P,0.01; P,0.05). In the
ovine model of PCOS, OD causes a sustained reduction in ovarian stromal blood flow with an increased ovarian artery
resistance index associated with atresia of antral follicles.
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Introduction
Polycystic ovary syndrome (PCOS), the most prevalent endo-
crine disorder in women of reproductive age [1,2], is the leading
cause of anovulatory related infertility [2,3]. Several treatment
options to induce ovulation are available, the first-line treatment
being the anti-estrogen clomifene citrate (CC). Although CC is
successful at inducing ovulation in approximately 50–80% of
cases, pregnancy rates are suboptimal. This is thought to arise due
to the anti-estrogenic effects of CC on the endometrium and
luteinising hormone surge [4,5]. Second-line treatment options are
used for women who fail to ovulate and/or conceive in response to
CC.
Ovulation induction using gonadotrophins is an effective
second-line treatment following CC resistance or failure [6].
Indeed it has been reported that follicle stimulating hormone
therapy results in higher pregnancy rates than CC treatment [7,8].
However such treatment is expensive, requires enhanced moni-
toring to reduce ovarian hyperstimulation and multiple pregnancy
rates and it is not available in all secondary care settings.
Therefore, in the UK, laparoscopic ovarian diathermy/drilling
(LOD) is also recommended as a second-line treatment for
anovulatory PCOS by the National Institute for Health and Care
Excellence (NICE).
LOD involves puncturing the ovarian surface in several sites,
under direct visualisation, either by diathermy or laser [9]. It can
be successful at inducing unifollcullar ovulation and pregnancy
without the drawback of endometrial thinning, ovarian hyper-
stimulation and multiple pregnancies [10,11]. It has the added
benefit of being a single treatment that can improve ovulation for
many months, and sometimes years, subsequently [12]. However,
as an invasive procedure it requires a general anaesthetic and
abdominal surgery, which presents increased risks and additional
morbidity. We therefore hypothesised that a medical diathermy
paradigm, which mimicked the mode of action of surgical
diathermy and encompassed the benefits of LOD, without the
pitfalls of surgery, would be an advantageous therapeutic option
for PCOS.
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There are two key requirements needed to develop pharma-
ceutical strategies to replicate the effects of diathermy on the
ovary. The first is a deeper understanding of the acute and chronic
effects of surgical diathermy on the polycystic ovary to increase
insights into its mechanism of action. Mechanistic insights are
lacking as the human ovary is not accessible for in vitro
investigation following diathermy. The second is a clinically
realistic preclinical model of anovulatory PCOS to develop and
test novel medical strategies for ovulation induction. We aimed to
assess the cellular, molecular and vascular effects of ovarian
diathermy on the ovary using a large animal model of PCOS.
Herein we report the effects of ovarian diathermy in an
established ovine model of anovulatory PCOS. We used the
paradigm of prenatal androgenisation from day 30 to day 100 of
gestation in sheep to create offspring who develop a robust PCOS-
like condition. We studied these offspring in the second breeding
season when the anovulatory PCOS-like phenotype is fully
established [13–19].
Materials and Methods
Ethical Statement
Studies were reviewed by University of Edinburgh Animal
Research Ethics Committee and conducted under Project Licence
approved by the UK Home Office.
Reagents
All reagents and chemicals were obtained from Sigma-Aldrich
(Dorset, United Kingdom), unless stated otherwise. Progesterone
was measured in weekly plasma samples by radioimmunoassay as
described previously [20]. This was used to confirm anovulation
prior to diathermy and assess the effect of ovarian diathermy on
the induction of ovulation.
Animal treatments
Scottish Greyface ewes (Ovis aries) of comparable body
condition score were cycle-synchronised using progesterone
sponges and mated with Texel rams. Pregnant ewes received
intramuscular injections of 100 mg testosterone propionate (TP;
AMS Biotechnology Ltd, Abingdon, United Kingdom) in vegeta-
ble oil twice weekly, from day (d) 30 to 100 of gestation (d147) and
delivered normally. After weaning, the resulting female offspring
were housed together in spacious pens and hay was available ad
libitum, with Excel Ewe Nuts (0.5–1.0 kg/day; Carrs Billington,
Lancashire, UK) and Cystalayx Extra High Energy Lick (Caltech
Solway Mills, Cumbria, UK). These offspring (n = 12) were
maintained until they were adults in their second breeding season
(22 months of age) after confirmation of anovulation by serial
progesterone assessment for eight weeks prior to randomisation.
The sheep were then randomly divided into three PCOS
cohorts (Table 1). The acute cohort (n = 4) were used to investigate
the early cellular, molecular and vascular effects of diathermy on
the ovary. They underwent mini-laparotomy, ovarian assessment
and unilateral ovarian diathermy, allowing the other ovary to
serve as an internal control. Twenty four hours later they
underwent mini-laparotomy, ovarian assessment and ovarian
collection under terminal anaesthesia. The chronic cohort (n = 8)
studied the later effects of diathermy on the ovary. A treatment
group (n = 4) underwent mini-laparotomy, ovarian assessment and
bilateral ovarian diathermy whilst the control group (n = 4)
underwent mini-laparotomy and ovarian assessment without
diathermy. Five weeks later they underwent mini-laparotomy,
ovarian assessment and ovarian collection under terminal anaes-
thesia. The study was completed in the last month of the breeding
season when ovulation would still be expected.
Table 1. Summary of treatment and investigation including contrast enhances ultrasound (CEUS) and reverse transcription
polymerase chain reaction (RT-PCR).
Acute (n=4) Chronic (n =4) Chronic (n =4)
Ovary 1 Ovary 2 Ovary 1 Ovary 2 Ovary 1 Ovary 2
Diathermy Control Diathermy Diathermy Control Control
Pre-Treatment
CEUS 3 3
Doppler 3 3 3 3 3 3
Resistance Index 3 3 3 3 3 3
Post- Immediate
CEUS 3 3
Post- 24 hours
CEUS 3 3
Doppler 3 3
Resistance Index 3 3
Histology 3 3
RT-PCR 3 3
Post- 5 weeks
Doppler 3 3 3 3
Resistance Index 3 3 3 3
Histology 3 3 3 3
RT-PCR 3 3 3 3
doi:10.1371/journal.pone.0111280.t001
Ovarian Effects of Diathermy in Model of PCOS
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Diathermy protocol
A mini-laparotomy was performed with sterile technique under
general anaesthesia, induced using isoflourane (Isoflo, Abbott
Animal Health, Maidenhead, UK). A midline incision exposed the
ovaries that were stabilised with a clamp to the uterine fundus.
Ovarian diathermy was performed using a needle probe with
monopolar coagulation current (Surgitran, STW-100). The
coagulation current was applied to the ovary at four separate sites
of approximately 4 mm in depth for 10 seconds. Ovarian blood
flow and ovarian artery resistance index were assessed prior to and
after diathermy. Following surgery, all sheep received antibiotics
(Penicillin and Dihydrostreptomycin), analgesics and they were
carefully monitored during their rapid recovery.
In vivo measurement: Contrast enhanced ultrasound
(CEUS) of ovarian capillary bed
All ultrasound imaging was undertaken using a Philips iU22
ultrasound scanner (Philips Medical Systems, Bothwell, WA, USA)
with linear array transducers L9-3 and L15-7. Using microbubbles
along with ultrasound scanning provides a novel method to assess
the capillary bed of the ovary. A well-established house contrast
agent [21] was utilised. Briefly decafluorobutane microbubbles
were prepared by a standard sonication protocol from an aqueous
micellar dispersion of phosphatidylcholine (2 mg/ml; Avanti
Lipids) and PEG stearate (2 mg/ml; Stepan Kesso). Following
two days incubation under fluorocarbon atmosphere in the
refrigerator, microbubbles floated to the top of the reaction vessel
Table 2. List of the primer pairs used in SYBR Green quantitative real-time PCR.
Gene Forward Sequence (59– 39) Reverse Sequence (59–39)
GAPDH GGCGTGAACCACGAGAAGTATAA AAGCAGGGATGATGTTCTGG
IL1 CAGCCGTGCAGTCAGTAAAA GAAGCTCATGCAGAACACCA
IL6 AAATGACACCACCCCAAGCA CTCCAGAAGACCAGCAGTGG
IL8 CAGCAGAGCTCACAAGCATC TGTGGCCCACTCTCAATAACT
IL10 CCAGGATGGTGACTCGACTAGAC TGGCTCTGCTCTCCCAGAAC
TNF GGTGCCTCAGCCTCTTCT GAACCAGAGGCCTGTTGAAG
CCL2 GCTCCCACGCTGAAGCTTGAAT GATTGTCTTTAGACTCTTGGGTTGTGGAG
SOCS3 CTTCAGCTCCAAGAGCGAGT ACGCTGAGGGTGAAAAAGTG
VEGF TCTTCAAGCCATCCTGTGTG TGCATTCACATTTGTTGTGC
doi:10.1371/journal.pone.0111280.t002
Figure 1. The effect of ovarian diathermy on antral follicles. Immunohistochemistry for activated caspase 3 (brown) in antral follicle showing
positive staining (a) and negative staining for atresia (b). (c) Immunohistochemistry for Ki67 showing positive staining for proliferation (brown) in an
antral follicle. d) H&E stained mid ovarian section showing antral follicles. The proportion atretic follicles (black) and healthy follicles (white) in control
and diathermy ovaries after 24 hours (e) and 5 weeks (f). (g) The proportion of follicles positive (black) and negative (white) for Ki67 (black)
proliferation marker (g) and the number of antral follicles (h) in control and diathermy ovaries after 5 weeks. *P,0.05. Scale bar = 100 mm (a–c), 1 mm
(d).
doi:10.1371/journal.pone.0111280.g001
Ovarian Effects of Diathermy in Model of PCOS
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forming a thick cake. Infranatant containing micellar lipid was
removed and replaced with degassed perfluorocarbon-saturated
saline. Larger bubbles (in excess of 8–10 mm size) were removed
from the preparation by flotation in normal gravity. Microbubbles
in aqueous saline were then packaged in glass vials with Teflon-
lined rubber stoppers and sealed under perfluorocarbon atmo-
Figure 2. The effect of diathermy on the expression of candidate genes in the ovarian stroma. Twenty four hours after diathermy (n = 4)
there was no change in a) IL1, b) IL6, c) IL8, d) IL10, g) SOCS3, h) VEGF when compared to paired control ovaries (n = 4). There was decrease in e) TNF
and an increase in f) CCL2 expression. Five weeks after diathermy (n = 4 paired ovaries) there was no difference in the expression of i) IL1, j) IL6, k) IL8, l)
IL10, m) TNF, n) CCL2, o) SOCS3 and p) VEGF when compared to control (n = 4 paired ovaries. *P,0.05; **P,0.01.
doi:10.1371/journal.pone.0111280.g002
Ovarian Effects of Diathermy in Model of PCOS
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sphere. This preparation has a concentration of 109 microbubbles
per ml with a 2 mm average size.
A bolus (0.2 ml volume) was injected into a jugular vein catheter
followed by a 10 ml saline flush to ensure all contrast agent was
administered. This protocol provides good contrast in the ovary
while avoiding signal saturation at peak contrast. CEUS was
carried out in sheep destined for the acute analysis. The wash in
time (WIT) was recorded for contrast before diathermy, immedi-
ately after diathermy and 24 hours after diathermy in triplicate.
This is considered a reproducible measurement in the literature
[22–24]. Details of the protocol for calculating the WIT under
these conditions have been reported elsewhere [24].
In vivo measurement: Ovarian Blood Flow
The whole ovary was scanned in the longitudinal plane in
colour Doppler mode with fixed thresholding and video images
stored. Doppler scans were replayed back on the quantification
software (Q-LAB v6, Philips Healthcare, Andover, MA, USA) and
three images per ovary with the greatest area of blood flow were
chosen for quantification by two observers blinded to the
treatment groups. Using Image J software (http://rsbweb.nih.
gov/ij/) the area of total Doppler signal flow for each image was
quantified and averaged per ovary.
In vivo measurement: Resistance Index
The ovarian artery was identified using colour Doppler
assessment with an L15-7 ultrasound probe. Resistance index
(RI) of the ovarian artery was assessed using automatic RI
Figure 3. The effect of Diathermy on ovarian stromal microbubble transit time. A) Representative microbubble and greyscale scan with
area of interest in the stroma highlighted (arrow) and the transit time graphically illustrated. The wash in time before and immediately after (b)
diathermy (n = 4) and 24 hours after (c) diathermy.
doi:10.1371/journal.pone.0111280.g003
Ovarian Effects of Diathermy in Model of PCOS
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measurements calculated on the Philips iU22 Ultrasound system
backed up with manual measurement confirmation. A continuous
wave of at least five peaks was obtained and three separate
measurements were taken to give an average value. This was
repeated three times and the mean of the averaged values per
ovary used for analysis.
Tissue Collection
At the end of the study ewes were sacrificed. Ovaries were
collected and cut longitudinally into two sections (two thirds and
one third of the ovary). The smaller section was snap frozen and
stored at 280uC for subsequent dissection of an area of stroma
(1 mm3), from the inner aspect of the outer third at least 1 mm
from the ovarian surface, with no visible antral follicles, for RNA
extraction and gene analysis studies. The larger, two third portion
of the ovary was fixed in Bouins solution for 24 hours before
transferral to 70% ethanol for paraffin wax embedding, sectioning
and immunohistochemical study.
Immunohistochemistry
Ovarian sections (5 mm) from the middle of the ovary were
analysed. A representative section with maximal ovarian diameter,
informed by our previous study on the assessment of follicle
number in the ewe [20], underwent haematoxylin and eosin
(H&E) staining for subsequent antral follicle counting. Immuno-
histochemical analysis was also performed for markers of cell
proliferation (Ki67) and apoptosis (activated caspase 3). Ovarian
tissue sections were dewaxed and rehydrated. Sections then
underwent antigen retrieval in a decloaking chamber (Biocare
Medical, Concord, California) containing sodium citrate retrieval
buffer (0.01M, pH 6.0). Peroxidase quenching and blocking steps
were performed via incubation in 3% H2O2 for 10 minutes, avidin
and biotin blocking (Vector Laboratories Ltd, Peterborough,
United Kingdom) and finally 5% BSA diluted in 20% normal
serum from the host species of the secondary antibody. Primary
antibodies, diluted in appropriate serum were applied to sections
overnight at 4uC. After washing, secondary antibody was applied
to slides for 1 hour, followed by Vectastain ABC Elite tertiary
complex (PK-1600 series; Vector Laboratories) for 1 hour. Binding
was visualised with 3,39-diaminobenzidine (Dako, Cambridge,
United Kingdom) for 30 seconds. Sections were counterstained
with hematoxylin and mounted. Negative controls consisted of
either primary antibody incubated with a blocking peptide or, in
the absence of a specific blocking peptide, non-immune serum of
equivalent immunoglobulin concentrations.
Analysis of tissue sections
Two independent examiners, blinded to treatment, counted the
number of follicles with a clear fluid-filled antrum ($500 mm) from
a mid-section of the ovary [20]. The average antral follicle count
per ovarian section was recorded. Immunohistochemical staining
of whole ovary sections stained for proliferation (Ki67) and atresia
(activated caspase 3) were blindly examined by two independent
expert examiners. Each antral follicle was examined and staining
Figure 4. The effect of diathermy on Colour Doppler signal in the ovarian stroma. Representative ovarian scans with fixed threshold
Colour Doppler signals visible before (a) and 24 hours after ovarian diathermy (b). Area of fixed threshold Colour Doppler signal in the ovary before
and 24 hours (c) and 5 weeks (d) after diathermy. *P,0.05; **P,0.01.
doi:10.1371/journal.pone.0111280.g004
Ovarian Effects of Diathermy in Model of PCOS
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was divided into two classifications, positive (clearly positive
immunostaining present in multiple cells) and negative (scant/
absent immunopositive cells). Number of follicles per classification
was used for proportional analysis.
Quantitative Real Time (qRT) PCR
RNA was extracted from tissue using RNeasy mini spin columns
following manufacturer’s protocol and concentration measured
using NanoDrop 1000 Spectrophotometer. Complimentary DNA
(cDNA) was synthesised from 200 ng RNA in accordance with
manufacturer’s protocol (Applied Biosystems, California, USA).
Subsequently, qRT-PCR was performed using SYBR Green as
previously described [25]. Primer3 Input version 0.4, online
software, was used to design forward and reverse primers (Table 2)
from DNA sequences obtained from Ensembl Genome Browser,
sequences were checked for specificity using Basic Local Align-
ment Search Tool and validity confirmed as previously described
[26]. Real-time PCR reactions were carried out in duplicate 10 ml
reactions, negative controls consisted of cDNA reaction without
reverse transcriptase and a reaction replacing cDNA with
nuclease-free water. Melt curve analysis revealed a single amplicon
in all cases. GAPDH has been reported as a suitable internal
control for ovarian stromal gene expression [27] and target gene
expression was analysed relative to GAPDH and quantified using
the DCt method.
Statistical analysis
Proportional analysis was conducted using a Fishers exact test.
The means of two groups were compared with non-paired or
paired t-test where appropriate when the data was parametric with
equal variance and the Mann Whitney test when not. Where the
distribution was not normal logarithmic transformation was used
prior to statistical testing. A P value of less than 0.05 was
considered statistically significant.
Results
The effect of diathermy on antral follicles
We first assessed whether diathermy could induce atresia of
antral follicles. Using immunostaining for activated caspase 3 as a
Figure 5. The effect of diathermy on the ovarian artery resistance index (RI). Representative RI scans with Colour Doppler signal wave
quantification before (a) and 24 hours after ovarian diathermy (b). Quantified RI of the ovarian artery before and 24 hours (c) and 5 weeks (d) after
diathermy. *P,0.05.
doi:10.1371/journal.pone.0111280.g005
Ovarian Effects of Diathermy in Model of PCOS
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marker of atresia each follicle in the tissue section was classified as
positive (Fig. 1a) or negative (Fig. 1b) for atresia. The proportion
of intact antral follicles with marked caspase 3 immunostaining
increased more than four-fold (P,0.05) 24 hours after diathermy
(Fig. 1e). Five weeks after diathermy the proportion of atretic
follicles was less (Fig. 1f) but there was still a significantly increased
proportion of follicles undergoing atresia (P,0.05). We then
investigated whether diathermy altered follicular proliferation in
the long term. Using immunostaining for the proliferation marker
Ki67 (Fig. 1c) we classified each follicle as negative or positive.
The proportion of antral follicles with marked Ki67 staining was
not altered five weeks after diathermy (Fig. 1 g). However the
overall number of antral follicles per ovarian tissue section
(Fig. 1d) was reduced five weeks after diathermy (P,0.05)
(Fig. 1 h).
Expression of inflammatory markers in the ovarian
stroma
We next assessed the early and late effects of diathermy on the
expression of genes associated with inflammation in the ovarian
stroma. Expression of IL1 tended to increase 24 hours after
diathermy but this did not reach statistical significance (P= 0.06)
(Fig. 2a). At this time point there was no difference in the
expression of IL6 (Fig. 2b), IL8 (Fig. 2c) or IL10 (Fig. 2d).
However, twenty-four hours after diathermy TNF expression was
reduced (P,0.05) (Fig. 2e) while the macrophage chemokine
CCL2 was up-regulated (P,0.01) (Fig. 2f). There was no
difference in the cytokine regulator SOCS3 (Fig. 2 g) or the
expression of VEGF (Fig. 2 h) 24 hours after diathermy. Five
weeks after diathermy there was no difference in IL1 (Fig. 2i)
(P= 0.09), TNF (Fig. 2 m), CCL2 (Fig. 2n) or any of the other
genes analysed (Fig. 2).
The effect of diathermy on vascular indices
In order to assess flow in the ovarian microvasculature we
assessed the wash in time (WIT) of sub-capillary sized micro-
bubbles using CEUS (Fig. 3a). Immediately after diathermy there
was a strong trend towards increased time for the microbubbles to
wash through the ovarian microasculature (Fig. 3b) (P= 0.05).
However this was not evident 24 hours after diathermy (Fig. 3c).
Interestingly there was an effect on larger vessels evident after 24
hours. The area of Doppler flow measurement was quantified in
scanned ovaries before diathermy (Fig. 4a) and 24 hours (Fig. 4b)
and five weeks after diathermy. There was no difference in
coloured Doppler signal area in control ovaries after 24 h hours
and five weeks. After diathermy there was a significant reduction
in Doppler signal area after 24 hours (P,0.05) (Fig. 4c) that
persisted after five weeks (P,0.01) (Fig. 4d), suggesting a persistent
reduction in vascular volume of larger ovarian vessels. This was
associated with an increase in ovarian arterial resistance index
(Fig. 5a, b) that was present after 24 hours (P,0.05) (Fig. 5c) and
persisted at five weeks (P,0.05) (Fig. 5d).
The effect of diathermy on ovarian function
Serial progesterone measurements were used to determine
whether diathermy could induce ovulation in the anovulatory
ovine model of PCOS. Although prior to randomisation the sheep
were anovulatory, one ovulation was detected in a single sheep
before diathermy was conducted (Fig. 6a). Interestingly no sheep
ovulated after treatment in either the control PCOS or diathermy
PCOS groups (Fig. 6b).
Discussion
The aim of this study was to identify the cellular, molecular and
vascular effects of ovarian diathermy on the ovary in order to
inform development of a potential novel therapeutic target to
stimulate ovulation in PCOS. We found that diathermy increases
follicular atresia and thus decreased the number of antral follicles
in the ovary. There is a putative early increase in local
inflammation but the most striking findings were the effects on
the intra-ovarian vasculature. There were immediate effects on the
microvasculature and prolonged effects on the ovarian Doppler
signal and arterial resistance index.
A hallmark of PCOS is increased synthesis and secretion of
ovarian androgens [1]. The theca cells of the follicle are the source
of these androgens and in the polycystic ovary these cells have an
enhanced capacity for androgen synthesis [20,28,29]. In addition,
a polycystic ovary has multiple functional antral follicles that
contain a viable oocyte [30,31] but are not proliferating or
undergoing atresia [32,33]. This means that, in addition to
enhanced theca cell function, there is increased theca cell mass in
the polycystic ovary. As androgens promote the polycystic ovarian
morphology and inhibit the growth of dominant follicles [34], the
increased functional mass of theca cells promotes ovarian
dysfunction.
It has been proposed that diathermy works by decreasing the
load of androgen producing cells within the ovary [35] and our
Figure 6. Representative serial plasma progesterone assess-
ment in the sheep with oligoovulation (a) and a representative
sheep with anovulation (b). The timing of diathermy is indicated by
the arrow.
doi:10.1371/journal.pone.0111280.g006
Ovarian Effects of Diathermy in Model of PCOS
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study supports this hypothesis. We observed that increased
follicular atresia and thus decreased numbers of antral follicles in
the ovary as a consequence of diathermy, thereby reducing theca
cell mass within the ovary. In women diathermy can induce
systemic hormone changes within days of surgery, including
reduced systemic androgen concentrations [12,36]. A decrease in
androgen production would presumably decrease androgen
inhibition on follicular maturation beyond the antral stage
[12,34,36]. Our data would be consistent with one key effect of
diathermy at the level of the ovary being the induction of atresia of
the accumulated functional follicles.
We wondered if this induced follicular atresia was due to
induction of inflammation locally that is detrimental to the health
of neighbouring follicles. Diathermy to any tissue induces
inflammation and it is therefore unsurprising that we report
alterations in the expression of selected inflammatory genes in the
ovarian stroma. In a study investigating diathermy in a normal
sheep ovary, the authors report an early neutrophil response
followed by a macrophage response [37]. We report early
increased expression of the macrophage chemotractant CCL2
[38] that would suggest stimulation of macrophage influx.
However TNF, a major macrophage product [39], was signifi-
cantly reduced suggesting that at 24 hours the inflammatory
response was still developing.
In the diathermy study of the normal ovine ovary increased
inflammatory processes remained apparent at 19 days post-
treatment and was suggested to continue beyond this timeframe
[37]. In women, increased ovarian volume post diathermy was
attributed to inflammation and as ovarian volume decreased at 3
weeks post-treatment it was suggested that inflammation was
resolving at that stage [40]. In our study we could find no evidence
of ongoing inflammation at a molecular level after five weeks. This
would be consistent with diathermy causing early but transient
inflammation within the ovary.
We know that macrophages and macrophage products are
involved in removing steroidogenic cells from the ovary. The
corpus luteum is a transient steroidogenic gland in the ovary that is
removed during luteolysis [41]. This involves an influx of
macrophages [42] as well as an increase in chemokines and
inflammatory markers [41,43]. These products can inhibit
steroidogenic cell function and survival [44,45]. It is therefore
possible that inflammation itself is responsible for the loss of theca
cell mass. However it should be noted that self-limiting inflam-
mation is common in the normal ovary as a part of normal ovarian
physiology [46,47].
It is more plausible that it is the effect on the ovarian blood
supply rather than inflammation per se that is key to increasing
follicular atresia and thus theca cell mass. Ovarian stromal blood
supply is increased in women with PCOS [48–50]. The ovarian
artery resistance index was lower in women with PCOS when
compared to matched controls [51,52] suggesting less impedance
to blood flow and ultimately increased ovarian vascularity. It is
likely that increased blood supply is important in maintenance of
the increased follicular mass of the polycystic ovary.
Using CEUS in the anovulatory ovary for the first time we
showed that diathermy had an immediate effect on the microvas-
cular circulation. The wash in time is similar to the mean transit
time and proportional to the ratio of volume to flow [23].
Considering the significant reduction of volume, the initial WIT
increase implies a significant decrease in flow immediately after
diathermy. Further, assuming that the vascular volume is not
recovered within 24 hours, the decrease in wash in time shows at
least a partial recovery of microvascular flow within 24 hours.
Colour Doppler showed there was an effect on the stromal
vascular volume, which is derived from bigger vessels, that persists
for the five weeks analysed. This is corroborated by the associated
increased arterial vascular resistance index, which confirms a
persistent reduction intraovarian blood circulation. In women
ovarian diathermy has been shown to increase the ovarian artery
resistance index [53]. These results are consistent with diathermy
having an immediate effect on the vasculature that is maintained
for the five weeks of this study.
Thus it might be that targeting the ovarian vasculature would be
a possible therapeutic strategy in PCOS. VEGF, a potent
angiogenic factor is increased in women with PCOS [50,54] and
may be responsible for the increased vascularisation. Serum
VEGF is reduced by diathermy in women [55]. We saw no
changes in stromal VEGF expression, which is not surprising as
the follicles are the primary source of VEGF in the ovary [56].
Blocking VEGF using VEGF Trap or monoclonal antibodies has
utility in blocking angiogenesis in ovarian cancer [57]. In the
normal primate ovary it reduces theca cell angiogenesis [58] and
induces antral follicle atresia [56]. Indeed we have previously
suggested its use as a possible treatment in PCOS [59]. Recently it
was reported that VEGF Trap may benefit ovarian function in a
rodent model of PCOS [60].
Unfortunately in our model diathermy did not induce ovulation.
We did not look in detail at the endocrine changes induced by
diathermy in this model as they have been well described in
women and were outside the aims of this study. It may be the
diathermy strategy or the ovine PCOS model induced by prenatal
programming that requires refinement for further study. With
regards to the diathermy strategy there is some evidence that the
adjustment of thermal dose to ovarian volume may be better that
the fixed dose regimen used in this study [61]. There may be an
increased hypothalamic pituitary contribution to the anovulatory
phenotype in the prenatally androgenised ewe. In this model we
used the conventional treatment where prenatal androgens are
started at d30 that has a more extreme phenotype [19] than our
refined model where androgens are started at d60 gestation
[20,62]. In addition we have not assessed the effect of diathermy
on ovaries from ovulatory sheep not programmed to have PCOS.
While this has been done previously the effect of diathermy on
ovulation was not an outcome of that study [37].
It is however clear that diathermy works best in women who are
slim without marked metabolic abnormalities [12,63,64]. We and
others have shown insulin resistance and other metabolic
abnormalities in the ovine PCOS model [17,26,62]. It could be
therefore speculated that the sheep model parallels the more obese
women with PCOS with metabolic dysfunction. Indeed insulin
sensitisers improve outcomes in these women with PCOS [65–67],
and in an ovine PCOS model rosiglitazone prevented the cycle
deteriation that is characteristic of these sheep as the breeding
season progresses [68].
A medical alternative to surgical diathermy remains attractive.
It is possible that targeting the increased ovarian vasculature in
PCOS may have utility. However we have shown that the ovine
PCOS model does not respond to conventional diathermy by
ovulating. This means that a preclinical model to assess novel
diathermy-like treatments is not currently established.
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